Gregory Roufa & David Glowacki are Building Digital Group Therapeutics | Psychedelic Invest Podcast

Sweet drinks, sour outcomes: a global health wake-up call

Sugar-sweetened beverages contribute significantly to global burdens of type 2 diabetes and cardiovascular disease, with disparities driven by age, education, and region. This study emphasizes

January 8, 2025

Up and down the ladder: The latest comings and goings

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s

May 10, 2024

Nuvig raises $161M as it prepares for Phase 2 study in hot autoimmune field

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

December 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.